Hospital Universitario 12 de Octubre — Madrid, Madrid

Public research footprint of Hospital Universitario 12 de Octubre, compiled from the ClinicalTrials.gov public registry.

1,591

Registered studies

649

Active

341

Recruiting now

660

Completed

193

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Small Cell Lung Cancer · ALK-positive Non-small Cell Lung Cancer (NSCLC) · Colorectal Cancer

Recently updated registry entries

NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT04221542 — Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer (Recruiting)
NCT07284849 — A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hospital Universitario 12 de Octubre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.